We report the cloning and expression pattern of a novel Ste20-type kinase gene, NIK-related kinase (Nrk), located on the mouse X chromosome. The full-length Nrk cDNA encodes a 1455-amino-acid polypeptide characterized by a N-terminal Ste20-type catalytic domain and a C-terminal regulatory domain characteristic of the group I GCK subfamily. The overall structure of the NRK protein is closely related to that of Nck-interacting kinase (Nik). In situ hybridization revealed that Nrk was predominantly expressed in skeletal muscle during mouse embryogenesis. Nrk gene expression was detected in the myotome at 10.5 dpc and, thereafter, was observed in developing skeletal musculature from 11.5 to 13.5 dpc. However, expression in skeletal muscle was not observed in adults. q
Results and discussion
The Ste20-type kinase family, which is believed to regulate MAP kinase cascades (Cobb et al., 1994; Schlesinger et al., 1998; Liu et al., 1999) , is divided into three subfamilies in higher eukaryotes based on its overall protein structure: (1) PAK subfamily characterized by a p21-binding domain; (2) Group I germinal center kinase (GCK) subfamily characterized by a C-terminal regulatory domain; and (3) Group II GCK subfamily which contains neither of the above domains (Kyriakis, 1999) . Many members of the group I GCK subfamily have been shown to activate the JNK/ SAPK pathway of MAP kinase cascades (Pombo et al., 1995; Hu et al., 1996; Kiefer et al., 1996; Su et al., 1997; Tung and Blenis, 1997) .
In this study, we cloned a full-length cDNA encoding a novel Ste20-type kinase from a 11.5 dpc mouse cDNA library (accession number AB020741). Its deduced amino acid structure is characterized by: (1) a Ste20-type catalytic domain at N-terminal region; (2) an intermediate region which contains one coiled-coil structure and ®ve putative SH3-binding sites; and (3) a C-terminal domain conserved among members of the group I GCK subfamily such as Nckinteracting kinase (NIK) (Su et al., 1997) , GCK (Katz et al., 1994) , kinase homologous to SPS1/STE20 (KHS; Tung and Blenis, 1997) , and hematopoietic progenitor kinase (HPK; Hu et al., 1996) (Fig. 1A,B) . Due to the structural similarities with NIK, we named this gene NIK-related kinase (Nrk). Linkage analysis showed that Nrk is located on the mouse X chromosome and is 1.9 cM distal to DXMit3. These ®ndings indicate that Nrk is a novel X-linked NIKrelated kinase gene belonging to the group I GCK subfamily.
Many members of the Ste20 family, including NIK and GCK, have been reported to be widely expressed in various tissues and cell types (Katz et al., 1994; Su et al., 1997; Schinkmann and Blenis, 1997; Pytowski et al., 1998) . In contrast, whole mount in situ hybridization analysis revealed that Nrk was predominantly expressed in skeletal muscle during mouse embryogenesis. Nrk expression was not observed between 7.5 and 9.5 dpc, although Myogenin, a myogenic transcription factor, was activated around at 8.5± 9.5 dpc ( Fig. 2A,B) . Nrk expression was ®rst observed in the ventral myotome at 10.5 dpc (Fig. 2C±J ). At 11.5 dpc, strong expression of Nrk was observed in the myotome E-mail address: aykanai@mail.ecc.u-tokyo.ac.jp (Y. Kanai) along the entire anterior-posterior axis, as well as in developing limb buds (Fig. 2K±N ). Nrk expression domains in the trunk and limbs were similar to, but extended over a wider range than, those of Myogenin-expressing cells. Such ®nd- ings suggest that Nrk expression may be not restricted to the terminal differentiation step of myogenesis, although comparative analysis using a double-labeling technique with various muscle markers should be required for further study. From 12.5 to 13.5 dpc, Nrk expression was observed throughout the developing skeletal musculature within the trunk, limbs, neck and cheek (Fig. 2O±T) . Northern blot analysis showed that Nrk was transcribed in the 11 dpc embryo and that expression increased from 15 to 17 dpc. This expression may coincide with the relative increase of skeletal muscle during embryogenesis (Fig.  1C) . Semi-quantitative RT-PCR analysis also con®rmed that Nrk is expressed in tissues containing skeletal muscle (e.g. limb buds, trunk) of 11.5 and 15.5 dpc embryos; however, only low level expression was detected in the heart of the 15.5 dpc embryo (Fig. 1D) . In contrast, Nrk expression was not detected in any of the adult tissues examined, including skeletal muscle (Fig. 1C,D ). These results demonstrate that the muscle-predominant expression of Nrk during embryogenesis is down-regulated as development proceeds.
Recently, misshapen in Drosophila and mig15 in C. elegans, both structurally similar to mammalian NIK, have been shown to be essential for dorsal closure, and Q-neuroblast migration and muscle arm targeting, respectively (Su et al., 1998) . Since Nrk is also a novel NIK-related kinase gene with a skeletal muscle-predominant expression, further characterization of this gene may shed light on signal transduction in the development and maturation of skeletal muscle.
Methods

Isolation of Nrk cDNA and genetic mapping
We isolated Nrk cDNA fragments by a PCR-based approach using degenerate primers for the kinase domain (Wilks, 1989) and further isolated the full length cDNA clone from 11.5 dpc mouse cDNA Lambda gt11 and gt10 libraries (CLONTECH). Linkage mapping was carried out using an intersubspeci®c backcross panel constructed with C57BL/6J and Mus m. molossinus, as previously described (Okamoto et al., 1995; Suhara et al., 1996) .
RNA expression analysis
cDNA fragments (1020 bp) corresponding to the Nrk intermediate region were used as a Nrk-speci®c probe. The Myogenin-speci®c probe (Fujisawa-Sehara et al., 1990) was kindly provided by Dr A. Fujisawa-Sehara. Whole-mount in situ hybridization was performed as described by Wilkinson and Nieto (1993) . After wholemount in situ hybridization, embryos were sectioned at 10±20 mm thickness. Multiple tissue Northern blots, each containing 2 mg-poly(A) 1 RNA per sample (CLONTECH), were hybridized with 32 P-labeled probes as described previously (Kanai et al., 1996) . cDNA samples were transcribed from 1 mg of total RNA and ampli®ed via PCR using Nrk-speci®c primers (Forward: 5 H -CTTGACAAAA-CATCTTACTGGGATC-3 H ; Reverse: 5 H -TGTATTGT-CCTGAGAATGTA GAGGC-3 H ), HPRT primers (KanaiAzuma et al., 1997) , and Myogenin primers (Yagami-Hiromasa et al., 1995) .
